Adherium Limited (ASX:ADR)
0.0020
0.00 (0.00%)
Apr 20, 2026, 9:59 AM AEST
Adherium Market Cap
Adherium has a market cap or net worth of 10.75 million as of April 28, 2026. Its market cap has increased by 41.68% in one year.
Market Cap
10.75M
Enterprise Value
11.43M
Revenue
1.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since August 26, 2015, Adherium's market cap has decreased from 732.84M to 10.75M, a decrease of -98.53%. That is a compound annual growth rate of -32.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 10.75M | -29.88% |
| Dec 31, 2025 | 15.33M | 44.33% |
| Dec 31, 2024 | 10.62M | -43.13% |
| Dec 29, 2023 | 18.67M | -6.25% |
| Dec 29, 2022 | 19.92M | -17.73% |
| Dec 31, 2021 | 24.21M | 27.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nova Eye Medical | 41.30M |
| CleanSpace Holdings | 34.72M |
| ImpediMed | 30.58M |
| CurveBeam AI | 28.19M |
| Atomo Diagnostics | 24.33M |
| Control Bionics | 22.66M |
| CONNEQT Health | 20.82M |
| OncoSil Medical | 15.96M |